spot_img
Sunday, September 25, 2022
More
    HomeHealthSTAT+: Amgen to acquire ChemoCentryx for $4 billion, adding newly approved drug...

    STAT+: Amgen to acquire ChemoCentryx for $4 billion, adding newly approved drug for autoimmune disorder

    -



    Amgen stated Thursday that it’ll purchase the small drugmaker ChemoCentryx for $4 billion to acquire a newly accepted medication that treats sufferers with a severe autoimmune situation.

    ChemoCentryx is being bought for $52 per share, or a 116% premium to its Wednesday closing value.

    Continue to STAT+ to read the full story…



    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,501FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts